A fight over the future of cancer care is playing out in a behind-the-scenes battle over Dana-Farber Cancer Institute’s proposed new hospital, underscoring the intense stakes in the business breakup between two of Massachusetts’ most prominent health care brands.
Dana-Farber has proposed building a $1.7 billion, 300-bed cancer center as it severs its long-standing partnership with Brigham and Women’s, which provides in-hospital care for Dana patients.
But the acrimonious split between the two storied institutions took another turn when a new report from the state of Massachusetts revealed that Brigham’s corporate parent, Mass General Brigham, has been lobbying against the Dana-Farber project, saying it is unnecessary, too big, and would raise health care spending in the state.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.